Myriad Genetics (MYGN) Intangibles (2010 - 2026)

Myriad Genetics (MYGN) has reported Intangibles for 17 consecutive years, with $145.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Intangibles fell 43.42% year-over-year to $145.7 million; the TTM figure through Mar 2026 stood at $145.7 million (down 43.42% YoY), while the FY2025 annual figure was $153.4 million, down 41.54% from the prior year.
• Intangibles fell to $145.7 million in Q1 2026 per MYGN's latest filing, from $153.4 million in the prior quarter.
• Across five years, Intangibles topped out at $393.6 million in Q1 2022 and bottomed at $145.7 million in Q1 2026.
• Historically, Intangibles has averaged $299.2 million across 5 years, with a median of $340.9 million in 2024.
• Annual changes were most pronounced in 2023 — Intangibles slipped 3.83% — and 2025, when it slumped 47.81%.
• Myriad Genetics' Intangibles stood at $379.7 million in 2022, then slipped by 7.95% to $349.5 million in 2023, then retreated by 24.92% to $262.4 million in 2024, then slumped by 41.54% to $153.4 million in 2025, then decreased by 5.02% to $145.7 million in 2026.
• Business Quant data shows MYGN's Intangibles at $145.7 million in Q1 2026, $153.4 million in Q4 2025, and $163.1 million in Q3 2025.